This week, Fitch Ratings affirmed WakeMed’s AA- rating on its long-term debt — one of the four highest credit ratings — and Mr. DeVaughn has helped establish that secure financial standing.
Currently, WakeMed has almost 45 percent of the inpatient market share in Wake County, which Fitch analysts called a “key credit strength.” In the first six months of the 2012 fiscal year, WakeMed has posted an “excellent” 5.6 percent operating margin and a 14.1 percent EBITDA margin.
Mr. DeVaughn has also improved WakeMed’s liquidity, which Fitch analysts said is “solid” for its rating level. As of March 31, 2012, WakeMed had $572.8 million in unrestricted cash and investments, which equated to 240.7 days cash on hand and a cash-to-debt ratio of 129.3 percent.
Previously, Mr. DeVaughn was CFO of Johnston Memorial Hospital in Smithfield, N.C., and CFO of Halifax Regional Hospital in South Boston, Va. He is also a member of the American Institute of Certified Public Accountants and the North Carolina Association of CPAs.
More Articles on Hospital CFO Profiles:
CFO Bruce Burns: Delivering Operational Stability to Concord Hospital
CFO Jim Budzinski: Supporting WellStar Health System’s Financial Growth
CFO Cheryl Sadro: Taking the Reins of Memorial Health Care’s Financials
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
